Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

NCT00478140 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

NIH

Sponsor class

Stopped Due to slow accrual

Conditions

Adenocarcinoma of the Extrahepatic Bile Duct
Adenocarcinoma of the Gallbladder
Malignant Neoplasm
Recurrent Extrahepatic Bile Duct Cancer
Recurrent Gallbladder Cancer
Unresectable Extrahepatic Bile Duct Cancer
Unresectable Gallbladder Cancer

Interventions

BIOLOGICAL: trastuzumab
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)